Kristian Juul Sandahl

Papers

Total Citations

H-Index

About

Kristian Juul Sandahl is a leading researcher in urological oncology, with a primary focus on advancing prostate cancer diagnostics through magnetic resonance imaging (MRI)-guided biopsy techniques. His major contribution lies in systematically comparing the diagnostic efficacy of manually operated versus robot-assisted in-bore MRI targeted prostate biopsy (MO-MRGB vs. RA-MRGB), addressing a critical evidence gap in precision medicine. His landmark 2022 study, cited 9 times, provides foundational data on detection rates for clinically significant prostate cancer, directly informing clinical decision-making and technological adoption. This work demonstrates his commitment to improving cancer detection accuracy while minimizing unnecessary procedures. Sandahl’s research bridges radiology and urology, offering practical insights for optimizing biopsy workflows. His findings are particularly valuable for clinicians seeking to balance diagnostic yield with procedural efficiency, and his comparative analyses have shaped ongoing debates about automation in targeted biopsy. As a rising voice in image-guided interventions, Sandahl continues to influence how MRI-targeted techniques are implemented in routine practice, with his work serving as a benchmark for future studies on robotic assistance in prostate cancer diagnosis.